Metastatic status of sentinel lymph nodes in melanoma determined noninvasively with multispectral optoacoustic imaging

Science Translational Medicine

Volumn 7, Issue 317, 2015, Pages

  Stoffels, Ingo ^a,b   Morscher, Stefan ^c,d   Helfrich, Iris ^a,b   Hillen, Uwe ^a,b   Leyh, Julia ^a,b   Burton, Neal C ^c   Sardella, Thomas C P ^c   Claussen, Jing ^c   Poeppel, Thorsten D ^e   Bachmann, Hagen S ^a   Roesch, Alexander ^a,b   Griewank, Klaus ^a,b   Schadendorf, Dirk ^a,b   Gunzer, Matthias ^a   Klode, Joachim ^a,b  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c ITHERA MEDICAL GMBH   (Germany)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^e UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INDOCYANINE GREEN; MELANIN; TECHNETIUM 99M;

AMELANOTIC MELANOMA; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIAGNOSTIC TEST ACCURACY STUDY; ECHOGRAPHY; EX VIVO STUDY; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; GOLD STANDARD; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IN VIVO STUDY; LYMPHOSCINTIGRAPHY; MAJOR CLINICAL STUDY; MELANOMA; MULTISPECTRAL OPTOACOUSTIC TOMOGRAPHY; NON INVASIVE MEASUREMENT; PHOTOACOUSTIC TOMOGRAPHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RELIABILITY; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE METASTASIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; CANCER PATIENT; CLINICAL PROTOCOL; FEMALE; LYMPH NODE DISSECTION; MALE; MELANOMA CELL; MOUSE; NON INVASIVE PROCEDURE; NONHUMAN; PHOTOACOUSTICS;

EID: 84954420557     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.aad1278     Document Type: Article

References (46)

1. E. Livingstone, C. Windemuth-Kieselbach, T. K. Eigentler, R. Rompel, U. Trefzer, D. Nashan, S. Rotterdam, S. Ugurel, D. Schadendorf, A first prospective population-based analysis investigating the actual practice of melanoma diagnosis, treatment and follow-up. Eur. J. Cancer 47, 1977-1989 (2011).
2. C. M. Balch, Surgical management of regional lymph nodes in cutaneous melanoma. J. Am. Acad. Dermatol. 3, 511-524 (1980).
3. J. E. Gershenwald, M. I. Ross, Sentinel-lymph-node biopsy for cutaneous melanoma. N. Engl. J. Med. 364, 1738-1745 (2011).
4. D. L. Morton, J. F. Thompson, A. J. Cochran, N. Mozzillo, R. Elashoff, R. Essner, O. E. Nieweg, D. F. Roses, H. J. Hoekstra, C. P. Karakousis, D. S. Reintgen, B. J. Coventry, E. C. Glass, H.-J. Wang; MSLT Group, Sentinel-node biopsy or nodal observation in melanoma. N. Engl. J. Med. 355, 1307-1317 (2006).
5. J. E. Gershenwald, W. Thompson, P. F. Mansfield, J. E. Lee, M. I. Colome, C.-h. Tseng, J. J. Lee, C. M. Balch, D. S. Reintgen, M. I. Ross, Multi-institutional melanoma lymphatic mapping experience: The prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J. Clin. Oncol. 17, 976-983 (1999).
6. C. M. Balch, S.-J. Soong, J. E. Gershenwald, J. F. Thompson, D. S. Reintgen, N. Cascinelli, M. Urist, K. M. McMasters, M. I. Ross, J. M. Kirkwood, M. B. Atkins, J. A. Thompson, D. G. Coit, D. Byrd, R. Desmond, Y. Zhang, P.-Y. Liu, G. H. Lyman, A. Morabito, Prognostic factors analysis of 17, 600 melanoma patients: Validation of the American Joint Committee on Cancer melanoma staging system. J. Clin. Oncol. 19, 3622-3634 (2001).
7. I. Satzger, B. Völker, A. Meier, A. Kapp, R. Gutzmer, Criteria in sentinel lymph nodes of melanoma patients that predict involvement of nonsentinel lymph nodes. Ann. Surg. Oncol. 15, 1723-1732 (2008).
8. R. L. Morton, K. Howard, J. F. Thompson, The cost-effectiveness of sentinel node biopsy in patients with intermediate thickness primary cutaneous melanoma. Ann. Surg. Oncol. 16, 929-940 (2009).
9. C. M. Balch, J. E. Gershenwald, S.-J. Soong, J. F. Thompson, M. B. Atkins, D. R. Byrd, A. C. Buzaid, A. J. Cochran, D. G. Coit, S. Ding, A. M. Eggermont, K. T. Flaherty, P. A. Gimotty, J. M. Kirkwood, K. M. McMasters, M. C. Mihm Jr., D. L. Morton, M. I. Ross, A. J. Sober, V. K. Sondak, Final version of 2009 AJCC melanoma staging and classification. J. Clin. Oncol. 27, 6199-6206 (2009).
10. I. Stoffels, H. Von Der Stück, C. Boy, T. Pöppel, N. Körber, M. Weindorf, J. Dissemond, D. Schadendorf, J. Klode, Indocyanine green fluorescence-guided sentinel lymph node biopsy in dermatooncology. J. Dtsch. Dermatol. Ges. 10, 51-57 (2012).
11. A. C. J. Van Akkooi, M. G. Bouwhuis, J. H. W. De Wilt, M. Kliffen, P. I. M. Schmitz, A. M. M. Eggermont, Multivariable analysis comparing outcome after sentinel node biopsy or therapeutic lymph node dissection in patients with melanoma. Br. J. Surg. 94, 1293-1299 (2007).
12. J. M. Thomas, Sentinel-lymph-node biopsy for cutaneous melanoma. N. Engl. J. Med. 365, 569-570 (2011).
13. R. Riber-Hansen, N. Hastrup, O. Clemmensen, N. Behrendt, S. Klausen, M. Ramsing, E. Spaun, S. J. Hamilton-Dutoit, T. Steiniche, Treatment influencing down-staging in EORTC Melanoma Group sentinel node histological protocol compared with complete step-sectioning: A national multicentre study. Eur. J. Cancer 48, 347-352 (2012).
14. O. E. Nieweg, False-negative sentinel node biopsy. Ann. Surg. Oncol. 16, 2089-2091 (2009).
15. D. L. Morton, J. F. Thompson, A. J. Cochran, N. Mozzillo, O. E. Nieweg, D. F. Roses, H. J. Hoekstra, C. P. Karakousis, C. A. Puleo, B. J. Coventry, M. Kashani-Sabet, B. M. Smithers, E. Paul, W. G. Kraybill, J. G. McKinnon, H.-J. Wang, R. Elashoff, M. B. Faries; MSLT Group, Final trial report of sentinel-node biopsy versus nodal observation in melanoma. N. Engl. J. Med. 370, 599-609 (2014).
16. K. M. Tichauer, K. S. Samkoe, J. R. Gunn, S. C. Kanick, P. J. Hoopes, R. J. Barth, P. A. Kaufman, T. Hasan, B. W. Pogue, Microscopic lymph node tumor burden quantified by macroscopic dual-tracer molecular imaging. Nat. Med. 20, 1348-1353 (2014).
17. L. V. Wang, L. Gao, Photoacoustic microscopy and computed tomography: From bench to bedside. Annu. Rev. Biomed. Eng. 16, 155-185 (2014).
18. V. Ntziachristos, D. Razansky, Molecular imaging by means of multispectral optoacoustic tomography (MSOT). Chem. Rev. 110, 2783-2794 (2010).
19. C. Kim, K. H. Song, F. Gao, L. V. Wang, Sentinel lymph nodes and lymphatic vessels: Noninvasive dual-modality in vivo mapping by using indocyanine green in rats-Volumetric spectroscopic photoacoustic imaging and planar fluorescence imaging. Radiology 255, 442-450 (2010).
20. G. C. Langhout, D. J. Grootendorst, O. E. Nieweg, M. W. J. M. Wouters, J. A. Van Der Hage, J. Jose, H. Van Boven, W. Steenbergen, S. Manohar, T. J. M. Ruers, Detection of melanoma metastases in resected human lymph nodes by noninvasive multispectral photoacoustic imaging. Int. J. Biomed. Imaging 2014, 163652 (2014).
21. D. J. Grootendorst, J. Jose, M. W. Wouters, H. Van Boven, J. Van Der Hage, T. G. Van Leeuwen, W. Steenbergen, S. Manohar, T. J. M. Ruers, First experiences of photoacoustic imaging for detection of melanoma metastases in resected human lymph nodes. Lasers Surg. Med. 44, 541-549 (2012).
22. G. Balasundaram, C. J. H. Ho, K. Li, W. H. Driessen, U. S. Dinish, C. L. Wong, V. Ntziachristos, B. Liu, M. Olivo, Molecular photoacoustic imaging of breast cancer using an actively targeted conjugated polymer. Int. J. Nanomedicine 10, 387-397 (2015).
23. D. Razansky, N. J. Harlaar, J. L. Hillebrands, A. Taruttis, E. Herzog, C. J. Zeebregts, G. M. Van Dam, V. Ntziachristos, Multispectral optoacoustic tomography of matrix metalloproteinase activity in vulnerable human carotid plaques. Mol. Imaging Biol. 14, 277-285 (2012).
24. S. V. Hudson, J. S. Huang, W. Yin, S. Albeituni, J. Rush, A. Khanal, J. Yan, B. P. Ceresa, H. B. Frieboes, L. R. McNally, Targeted noninvasive imaging of EGFR-expressing orthotopic pancreatic cancer using multispectral optoacoustic tomography. Cancer Res. 74, 6271-6279 (2014).
25. J.-T. Oh, M.-L. Li, H. F. Zhang, K. Maslov, G. Stoica, L. V. Wang, Three-dimensional imaging of skin melanoma in vivo by dual-wavelength photoacoustic microscopy. J. Biomed. Opt. 11, 034032 (2006).
26. J. Stritzker, L. Kirscher, M. Scadeng, N. C Deliolanis, S. Morscher, P. Symvoulidis, K. Schaefer, Q. Zhang, L. Buckel, M. Hess, U. Donat, W. G. Bradley, V. Ntziachristos, A. A. Szalay, Vaccinia virus-mediated melanin production allows MR and optoacoustic deep tissue imaging and laser-induced thermotherapy of cancer. Proc. Natl. Acad. Sci. U. S. A. 110, 3316-3320 (2013).
27. D. McCormack, M. Al-Shaer, B. S. Goldschmidt, P. S. Dale, C. Henry, C. Papageorgio, K. Bhattacharyya, J. A. Viator, Photoacoustic detection of melanoma micrometastasis in sentinel lymph nodes. J. Biomech. Eng. 131, 074519 (2009).
28. N. K. Tafreshi, X. Huang, V. E. Moberg, N. M. Barkey, V. K. Sondak, H. Tian, D. L. Morse, J. Vagner, Synthesis and characterization of a melanoma-targeted fluorescence imaging probe by conjugation of a melanocortin 1 receptor (MC1R) specific ligand. Bioconjug. Chem. 23, 2451-2459 (2012).
29. I. Stoffels, J. Dissemond, T. Pöppel, D. Schadendorf, J. Klode, Intraoperative fluorescence imaging for sentinel lymph node detection: Prospective clinical trial to compare the usefulness of indocyanine green vs technetium Tc 99m for identification of sentinel lymph nodes. JAMA Surg. 150, 617-623 (2015).
30. C. Voit, A. C J. Van Akkooi, G. Schäfer-Hesterberg, A. Schoengen, K. Kowalczyk, J. C. Roewert, W. Sterry, A. M. M. Eggermont, Ultrasound morphology criteria predict metastatic disease of the sentinel nodes in patients with melanoma. J. Clin. Oncol. 28, 847-852 (2010).
31. M. G. Cook, M. A. Green, B. Anderson, A. M. M. Eggermont, D. J. Ruiter, A. Spatz, M. W. Kissin, B. W. E. M. Powell; EORTC Melanoma Group, The development of optimal pathological assessment of sentinel lymph nodes for melanoma. J. Pathol. 200, 314-319 (2003).
32. A. C Van Akkooi, M. G. Cook, A. M. Eggermont, Increased sampling will lead to an increase in detection, but is it clinically relevant? Reply letter regarding: "Treatment influencing down-staging in EORTC Melanoma Group sentinel node histological protocol compared with complete step-sectioning: A national multicentre study" by Riber-Hansen et al. Eur. J. Cancer 48, 2488-2489 (2012).
33. C. Mitteldorf, H. P. Bertsch, A. Zapf, C. Neumann, L. Kretschmer, Cutting a sentinel lymph node into slices is the optimal first step for examination of sentinel lymph nodes in melanoma patients. Mod. Pathol. 22, 1622-1627 (2009).
34. I. Stoffels, M. Müller, M. H. Geisel, J. Leyh, T. Pöppel, D. Schadendorf, J. Klode, Cost-effectiveness of preoperative SPECT/CT combined with lymphoscintigraphy vs. lymphoscintigraphy for sentinel lymph node excision in patients with cutaneous malignant melanoma. Eur. J. Nucl. Med. Mol. Imaging 41, 1723-1731 (2014).
35. W. L Cheung, R. R. Patel, A. Leonard, B. Firoz, S. A. Meehan, Amelanotic melanoma: A detailed morphologic analysis with clinicopathologic correlation of 75 cases. J. Cutan. Pathol. 39, 33-39 (2012).
36. A. E. Giuliano, A. J. Cochran, D. L. Morton, Melanoma from unknown primary site and amelanotic melanoma. Semin. Oncol. 9, 442-447 (1982).
37. I. Stoffels, C. Boy, T. Pöppel, J. Kuhn, K. Klötgen, J. Dissemond, D. Schadendorf, J. Klode, Association between sentinel lymph node excision with or without preoperative SPECT/CT and metastatic node detection and disease-free survival in melanoma. JAMA 308, 1007-1014 (2012).
38. C. Garbe, A. Hauschild, M. Volkenandt, D. Schadendorf, W. Stolz, U. Reinhold, R.-D. Kortmann, C. Kettelhack, B. Frerich, U. Keilholz, R. Dummer, G. Sebastian, W. Tilgen, G. Schuler, A. Mackensen, R. Kaufmann, Evidence-based and interdisciplinary consensus-based German guidelines: Systemic medical treatment of melanoma in the adjuvant and palliative setting. Melanoma Res. 18, 152-160 (2008).
39. I. Stoffels, J. Dissemond, A. Körber, U. Hillen, T. Poeppel, D. Schadendorf, J. Klode, Reliability and cost-effectiveness of sentinel lymph node excision under local anaesthesia versus general anaesthesia for malignant melanoma: A retrospective analysis in 300 patients with malignant melanoma AJCC Stages I and II. J. Eur. Acad. Dermatol. Venereol. 25, 306-310 (2011).
40. J. Klode, T. Poeppel, C. Boy, S. Mueller, D. Schadendorf, A. Körber, I. Stoffels, J. Dissemond, Advantages of preoperative hybrid SPECT/CT in detection of sentinel lymph nodes in cutaneous head and neck malignancies. J. Eur. Acad. Dermatol. Venereol. 25, 1213-1221 (2011).
41. L. Barthelmes, A. Goyal, R. G. Newcombe, F. McNeill, R. E. Mansel; NEW START and ALMANAC study groups, Adverse reactions to patent blue V dye-The NEW START and ALMANAC experience. Eur. J. Surg. Oncol. 36, 399-403 (2010).
42. M. Xu, L. V. Wang, Universal back-projection algorithm for photoacoustic computed tomography. Phys. Rev. E Stat. Nonlin. Soft Matter Phys. 71, 016706 (2005).
43. S. Tzoumas, N. Deliolanis, S. Morscher, V. Ntziachristos, Unmixing molecular agents from absorbing tissue in multispectral optoacoustic tomography. IEEE Trans. Med. Imaging 33, 48-60 (2014).
44. V. G. Prieto, S. H. Clark, Processing of sentinel lymph nodes for detection of metastatic melanoma. Ann. Diagn. Pathol. 6, 257-264 (2002).
45. C. Garbe, A. Hauschild, M. Volkenandt, D. Schadendorf, W. Stolz, U. Reinhold, R.-D. Kortmann, C. Kettelhack, B. Frerich, U. Keilholz, R. Dummer, G. Sebastian, W. Tilgen, G. Schuler, A. Mackensen, R. Kaufmann, Evidence and interdisciplinary consense-based German guidelines: Diagnosis and surveillance of melanoma. Melanoma Res. 17, 393-399 (2007).
46. J. A. Jensen, S. I. Nikolov, K. L. Gammelmark, M. H. Pedersen, Synthetic aperture ultrasound imaging. Ultrasonics 44(Suppl. 1), e5-e15 (2006).